Yescarta

Yescarta is a prescription immunotherapy used to treat certain types of large B-cell lymphoma, a form of blood cancer. It works by collecting and modifying a patient’s own immune cells (T cells) to better recognize and attack cancer cells. After the cells are treated in a lab, they are infused back into the patient to help combat the disease. Yescarta is typically used when the cancer has not responded to or has returned after other treatments. It offers a targeted, personalized approach, harnessing the immune system to fight cancer more effectively.